LENZ
Lenz Therapeutics
$3.21
+$0.06 (+1.9%)Oct 28, 2026
Key metrics
The numbers that frame LENZ today
- Market cap
- $100.86M
- Gross margin
- 91.7%
- EV / Sales
- 3.6
- ROIC
- -59.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.06
- 52wk High
- $32.10
Growth
Revenue and earnings trend for LENZ
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LENZ
Is Lenz Therapeutics a good buy?
No. Lenz Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Lenz Therapeutics is selling at a very high price.
What is the market capitalization of LENZ?
Lenz Therapeutics's market capitalization is $100.86M.
What is the 52-week high for LENZ stock?
The 52-week high for Lenz Therapeutics is $32.10. The current close of $3.21 is 90% below that high.
What is the 52-week low for LENZ stock?
The 52-week low for Lenz Therapeutics is $3.06. The current close of $3.21 is 4.9% above that low.
Does LENZ stock pay dividends?
Lenz Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LENZ?
Lenz Therapeutics's Debt / Equity ratio is 0.